Skip to content
10-Q

Quarterly Report

FV Pharma International Corp.

0001575872-15-000008

← back to feed
Filed
Feb 18, 2015 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2015 · Feb 12, 2015 250.8M sh
Cash And Equivalents Q3 2015 · Oct 31, 2014 $0
Cash And Equivalents Q3 2015 · Jan 31, 2014 $3.92K
Cash And Equivalents Q3 2015 · Oct 31, 2013 $2.48K
Cash And Equivalents Q3 2015 · Jan 31, 2013 $31.56K
Stockholders Equity Q3 2015 · Oct 31, 2014 −$35.94K
Stockholders Equity Q3 2015 · Jan 31, 2014 $6.52K
Current Liabilities Q3 2015 · Oct 31, 2014 $36.21K
Current Liabilities Q3 2015 · Jan 31, 2014 $0
Total Liabilities Q3 2015 · Oct 31, 2014 $36.21K
Total Liabilities Q3 2015 · Jan 31, 2014 $0
Current Assets Q3 2015 · Oct 31, 2014 $264
Current Assets Q3 2015 · Jan 31, 2014 $6.52K
Total Assets Q3 2015 · Oct 31, 2014 $264
Total Assets Q3 2015 · Jan 31, 2014 $6.52K
Sga Expense Q3 2015 · Oct 31, 2014 $1.22K
Sga Expense Q3 2015 · Oct 31, 2014 $42.46K
Sga Expense Q3 2015 · Oct 31, 2013 $14.66K
Sga Expense Q3 2015 · Oct 31, 2013 $26.48K
Net Income Q3 2015 · Oct 31, 2014 −$1.22K
Net Income Q3 2015 · Oct 31, 2014 −$42.46K
Net Income Q3 2015 · Oct 31, 2013 −$14.66K
Net Income Q3 2015 · Oct 31, 2013 −$26.48K
Revenue Q3 2015 · Oct 31, 2014 $0
Revenue Q3 2015 · Oct 31, 2014 $0
Revenue Q3 2015 · Oct 31, 2013 $0
Revenue Q3 2015 · Oct 31, 2013 $0
Operating Income Q3 2015 · Jan 31, 2014 $30.64K
Operating Income Q3 2015 · Jan 31, 2013 $1.76K
Stock Issued Q3 2015 · Dec 4, 2012 70.8M sh
Stock Issued Q3 2015 · Oct 22, 2012 180M sh